CoChat

Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort

Open access
Lopez-Cortes, L. E., Cisneros, J. M., Fernandez-Cuenca, F., Bou, G., Tomas, M., Garnacho-Montero, J., Pascual, A., Martinez-Martinez, L., Vila, J., Pachon, J., Rodriguez Bano, J., Porto, A. S., Vallejo, L., Perez, B. F., Villar Chao, J. C., Ortega, B. P., Mansilla, E. C., Garcia Irure, J. J., del Arco Jimenez, A., de la Torre Lima, J., Cardona, C. G., Abril, V., Pujals, J. V., Aguirre, M. N., Jimenez Alfaro, J. A., Jaca, C. R., Casanova, P. M., Guerreo, F., Mayoral, T. N., Fernandez Calavia, M. J., de Lucas, E. M., Zorraquino, A., Eseverri, E. G., Sanchez, L. L., Gutierrez, A. F., Guardado, A. R., Garcia-Arenzana Anguera, J. M., Palmero, S. L., Maresca, M. R., Garrote, F. G., Otero, J. V., Verdu, E. V., Lopez, F. R., Sanchez, F. P., Vizoso, E. F., Gurgui, M., Pericas, R., Olaechea Astigarraga, P. M., Igartua, R. A., Macia Romero, M. D., de Gopegui Bordes, E. R., Sanchez Romero, M. I., Mata, J. G., Goyanes, M. J., Quero, J. H., Lara, T. E., Bastardie, F. B., Iftimie, S., Galan Navarro, M. I., Cadiz Gurrea, M. L., Antequera, C. A., Gomez, M., Salas, C. M., Peragosa, J. C., Real, S. H., Carrero Gonzalez, P. A., Pallares Gonzalez, M. A., Fernandez, S. R., Rojo, M. P., Tubau, F., Alvarez, E. N., Torres, M. O., Almaraz, S. G., Hortelano, E., Sanchez, F. C., Reyne, A. G., Horcajada Gallego, J. P., Segura, C., Dorado, G. S., Escudero, R. Y., Dorta Hung, M. E., del Rosario Q, C., on behalf of the GEIH/REIPI-Ab2010 Group · 2014 · Journal of Antimicrobial Chemotherapy
Cited by 102

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) infection presents a challenge because of the scarcity of available options. Even though combination therapy (CT) is frequently used in clinical practice, data are needed to support its use instead of monotherapy (MT). METHODS: A prospective observational study was conducted in 28 Spanish hospitals. Patients with sepsis caused by MDRAB, defined according to strict criteria, and who received active antibiotic treatment (according to in vitro susceptibility testing) for at least 48 h, were included. The main outcome variable was all-cause 30 day mortality after initiation of targeted therapy. Multivariate analysis, including a propensity score (for receiving CT), was performed by Cox regression. RESULTS: One hundred and one patients were included in the analysis; 68 (67.3%) received MT and 33 (32.7%) received CT. Pneumonia was the most common infection (50.5%), 68.6% of cases being associated with mechanical ventilation. Colistin (67.6%) and carbapenems (14.7%) were the most common drugs used in MT; colistin plus tigecycline (27.3%) and carbapenem plus tigecycline (12.1%) were the most frequent combinations. Crude 30 day mortality was 23.5% and 24.2% for the MT and CT groups, respectively (RR = 1.03; 95% CI 0.49-2.16; P = 0.94). Multivariate analysis of 30 day survival showed no trend towards reduced 30 day mortality with CT (HR = 1.35; 95% CI 0.53-3.44; P = 0.53). Subgroup analysis showed similar results. CONCLUSIONS: Our data do not support an association of CT with reduced mortality in MDRAB infections. More data for specific types of infection and combinations are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dku233

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 102

Metadata

Authors
Lopez-Cortes, L. E., Cisneros, J. M., Fernandez-Cuenca, F., Bou, G., Tomas, M., Garnacho-Montero, J., Pascual, A., Martinez-Martinez, L., Vila, J., Pachon, J., Rodriguez Bano, J., Porto, A. S., Vallejo, L., Perez, B. F., Villar Chao, J. C., Ortega, B. P., Mansilla, E. C., Garcia Irure, J. J., del Arco Jimenez, A., de la Torre Lima, J., Cardona, C. G., Abril, V., Pujals, J. V., Aguirre, M. N., Jimenez Alfaro, J. A., Jaca, C. R., Casanova, P. M., Guerreo, F., Mayoral, T. N., Fernandez Calavia, M. J., de Lucas, E. M., Zorraquino, A., Eseverri, E. G., Sanchez, L. L., Gutierrez, A. F., Guardado, A. R., Garcia-Arenzana Anguera, J. M., Palmero, S. L., Maresca, M. R., Garrote, F. G., Otero, J. V., Verdu, E. V., Lopez, F. R., Sanchez, F. P., Vizoso, E. F., Gurgui, M., Pericas, R., Olaechea Astigarraga, P. M., Igartua, R. A., Macia Romero, M. D., de Gopegui Bordes, E. R., Sanchez Romero, M. I., Mata, J. G., Goyanes, M. J., Quero, J. H., Lara, T. E., Bastardie, F. B., Iftimie, S., Galan Navarro, M. I., Cadiz Gurrea, M. L., Antequera, C. A., Gomez, M., Salas, C. M., Peragosa, J. C., Real, S. H., Carrero Gonzalez, P. A., Pallares Gonzalez, M. A., Fernandez, S. R., Rojo, M. P., Tubau, F., Alvarez, E. N., Torres, M. O., Almaraz, S. G., Hortelano, E., Sanchez, F. C., Reyne, A. G., Horcajada Gallego, J. P., Segura, C., Dorado, G. S., Escudero, R. Y., Dorta Hung, M. E., del Rosario Q, C., & on behalf of the GEIH/REIPI-Ab2010 Group
Venue
Journal of Antimicrobial Chemotherapy
Published
2014-06-25
Volume
69
Issue
11
Pages
3119-3126
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2146732501
Cited by
102
References
3
FWCI
5.59
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.